Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations.
Shumilov E, Flach J, Joncourt R, Porret N, Wiedemann G, Angelillo-Scherrer A, Trümper L, Fiedler M, Jeker B, Amstutz U, Pabst T, Bacher U. Shumilov E, et al. Among authors: flach j. Hematol Oncol. 2019 Aug;37(3):319-322. doi: 10.1002/hon.2603. Epub 2019 Mar 28. Hematol Oncol. 2019. PMID: 30843248 Clinical Trial. No abstract available.
Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature.
Bürki S, Shumilov E, Bonadies N, Flach J, Legros M, Banz Y, Oppliger-Leibundgut E, Fiedler M, Angelillo-Scherrer A, Rovo A, Bacher U. Bürki S, et al. Among authors: flach j. Leuk Lymphoma. 2018 Sep;59(9):2233-2237. doi: 10.1080/10428194.2017.1416367. Epub 2018 Jan 3. Leuk Lymphoma. 2018. PMID: 29295644 Review. No abstract available.
Current status and trends in the diagnostics of AML and MDS.
Shumilov E, Flach J, Kohlmann A, Banz Y, Bonadies N, Fiedler M, Pabst T, Bacher U. Shumilov E, et al. Among authors: flach j. Blood Rev. 2018 Nov;32(6):508-519. doi: 10.1016/j.blre.2018.04.008. Epub 2018 Apr 27. Blood Rev. 2018. PMID: 29728319 Review.
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
Shumilov E, Flach J, Pabst T, Fiedler M, Angelillo-Scherrer A, Trümper L, Joncourt R, Kohlmann A, Bacher U. Shumilov E, et al. Among authors: flach j. Crit Rev Oncol Hematol. 2018 Jun;126:64-79. doi: 10.1016/j.critrevonc.2018.03.020. Epub 2018 Mar 29. Crit Rev Oncol Hematol. 2018. PMID: 29759569 Review.
95 results